Gladstone NOW: The Campaign Join Us on the Journey ✕
76 - 90 of 116 Results Clear All
Gladstone scientists receive funding to develop new drugs to reduce tau levels in the brain
Assay Development and Drug Discovery Core Alzheimer’s Disease Mucke Lab
Scientists develop a cheaper, quicker, and more reliable stem cell–based technology to facilitate drug discovery
Gan Lab Stem Cells/iPSCs Alzheimer’s Disease
A new center at Gladstone aims to find unforeseen uses for existing drugs
Huang Lab Stem Cells/iPSCs Alzheimer’s Disease
E-Scape Bio, a Gladstone spin-off company, extends its Series A financing to generate novel therapies to treat neurodegenerative disorders
Huang Lab Mahley Lab Alzheimer’s Disease
Gladstone scientists combine expertise in Alzheimer’s research with legacy as leaders in stem cell technology
Alzheimer’s Disease Gan Lab Huang Lab CRISPR/Gene Editing Stem Cells/iPSCs
Scientists discover an enzyme that that could be targeted to treat both Alzheimer’s disease and frontotemporal dementia.
Alzheimer’s Disease Finkbeiner Lab
Gladstone scientists discover how to control the cacophony of electrical activity in the brain, stopping seizures and reducing deficits related to Alzheimer’s disease.
Alzheimer’s Disease Epilepsy Mucke Lab Paz Lab Optogenetics
Scientists at the Gladstone Institutes take a comprehensive approach to dementia research, pursuing several potential causal factors of the disease in the hopes of discovering breakthrough treatments.
Alzheimer’s Disease Gan Lab Huang Lab Mucke Lab
Scientists at the Gladstone Institutes have discovered how the major genetic risk factor for Alzheimer’s disease causes memory impairment.
Alzheimer’s Disease Huang Lab
Jorge Palop has been appointed to assistant investigator at the Gladstone Institute of Neurological Disease.
Alzheimer’s Disease Palop Lab
Gladstone scientists have discovered how tau disrupts the ability of brain cells to form new memories in Alzheimer’s disease.
Alzheimer’s Disease Gan Lab
A cross-disciplinary collaboration seeks to connect the clinic and the laboratory and improve the translation of Alzheimer’s disease research.
Alzheimer’s Disease Finkbeiner Lab
New findings about Alzheimer’s disease advance the search for more effective treatments.
Alzheimer’s Disease Mucke Lab
Researchers from the Gladstone Institutes have shown for the first time that the protein BRCA1 is required for normal learning and memory and is depleted by Alzheimer’s disease.
Mucke Lab Alzheimer’s Disease
By repurposing a prescription drug used to treat rheumatoid arthritis, researchers at the Gladstone Institutes successfully reversed tau-related symptoms in an animal model of dementia.
Alzheimer’s Disease Gan Lab
